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The analgesic effects of three different doses of tramadol as a preanesthetic in 
medetomidine-ketamine anesthesia in dogs were compared. Twenty-eight healthy 
adult mongrel dogs were used. The dogs were divided into four groups at random; 1 
ml kg
-1 of normal saline, 1, 2 or 4mg kg
-1 of tramadol premedication (group Control, 
TRA1, TRA2 and TRA4) was then administered intravenously followed by 
medetomidine and ketamine anesthesia. The behavioral changes, the duration of 
surgical anesthesia, blood gas parameters (pH, pO2, and pCO2), heart rate, and 
systolic/diastolic pressure were observed. Tramadol (4mg kg
-1) pretreatment 
significantly increased the degree of sedation when compared with the control, 
TRA1 and TRA2 groups at 15 min after tramadol administration (P<0.05). The 
duration of surgical anesthesia was significantly increased by tramadol (4mg kg
-1) 
pretreatment when compared with that of the control group (P<0.05). There were no 
significant differences in behavioral changes, blood gas parameters (pH, pO2 and 
pCO2), heart rate, and arterial pressure among the groups. Tramadol at 4mg kg
-1 did 
not affect the cardiovascular system and recovery of anesthesia, but significantly 
increased the duration of surgical anesthesia with medetomidine and ketamine. This 
result suggests that intravenous tramadol at 4mg kg
-1 is a useful preanesthetic agent 
for extending the surgical level of anesthesia in medetomidine-ketamine anesthesia 
in dogs. 
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INTRODUCTION 
 
Tramadol is a centrally acting analgesic agent with 
activity at µ-opioid, adrenergic and 5-hydroxytryptamine 
(5-HT) receptors. Its analgesic effect is a result of its dual 
mechanism of action, that is, as a re-uptake inhibitor of 
norepinephrine and serotonin and agonist of the µ-opioid 
receptor (Bamigbade et al., 1997; Halfpenny et al., 1999; 
Ide et al., 2006). Tramadol has been in clinical use for the 
relief of mild to moderate pain in human and veterinary 
medicine (Buback et al., 1996; Yaddanapudi et al., 2000; 
Ozcengiz et al., 2001; Mastrocinque and Fantoni, 2003; 
Pypendop and Ilkiw, 2008). Tramadol is also used 
perioperatively in veterinary anesthesia as it significantly 
reduces the requirements of volatile anesthetics and opioid 
agents (Wordliczek et al., 2002; Seddighi et al., 2009). 
Although tramadol has relatively effective analgesic 
effects, a higher tramadol infusion rate was needed to 
reduce sevoflurane requirements in dogs (Seddighi et al.,  
(2009). Furthermore, recent results showed that tramadol 
exhibits different metabolic rates between species: 
tramadol is metabolized quickly to inactive 
metabolites in goats, horses and dogs (KuKanich and 
Papich, 2004; de Sousa et al., 2008; Shilo et al., 2008; 
Giorgi et al., 2009b), in contrast with cats and camels 
(Elghazali et al., 2008; Pypendop and Ilkiw, 2008).  
A combination of medetomidine and ketamine is 
commonly used for animal anesthesia (Nevalainen et al., 
1989; Verstegen et al., 1989; Jang et al., 2009). To our 
knowledge, use of tramadol as a preanesthetic agent in 
veterinary medicine is uncommon; in particular, we found 
no reports of preemptive treatment in medetomidine and 
ketamine anesthesia in dogs. The purpose of this study 
was to determine the safety and efficacy of tramadol as a 
preanesthetic during medetomidine and ketamine 
anesthesia in dogs through evaluation of the behavioral 
changes, the duration of surgical anesthesia, blood gas 
parameters, heart rate, and arterial pressure. 
 
MATERIALS AND METHODS 
 
Animals 
Twenty-eight adult mongrel dogs were used in the 
study. All animals were considered clinically healthy 
based on physical examination, complete blood count and 
serum biochemistry. The average weight of the dogs was 
RESEARCH ARTICLE Pak Vet J, 2011, 31(2): 99-104. 
 
100
5.7 ± 1.4 kg (3.9 to 10.0 kg). Each dog was housed 
individually and fed commercially available dry pellet 
food and water ad libitum. The dogs were randomly 
divided into 4 groups administered normal saline, 1, 2 or 
4mg kg
-1 of tramadol, followed by medetomidine and 
ketamine anesthesia (Control, TRA1, TRA2 and TRA4, 
respectively); each group contained 7 dogs. This study 
was approved by the Kyungpook National University 
Institutional Animal Care and Use Committee. 
 
Experimental procedure 
One day prior to the experiment, an arterial catheter 
was inserted about 5 cm into the right external carotid 
artery and forward toward the aorta of each dog under 
propofol and isoflurane anesthesia. The catheter was 
placed in a tunnel through the subcutis and brought out on 
the dorsal surface of the neck; it was then filled with 
heparin (50 IU mL
-1) diluted in saline. The arterial 
catheter was used for checking arterial blood pressure and 
heart rate and for collecting blood. The catheter was 
flushed with saline diluted in heparin two times a day to 
prevent coagulation of blood. 
Food but not water was withheld for 12 h before the 
experiment. On the day of the experiment, the dogs were 
acclimatized to the experimental room for 1 h, and then 
the arterial catheter was connected to a Polygraph (Model 
7P1, Grass Instrument Co., Quincy, MA). Following 
determination of baseline values in a sitting position, a 24-
gauge cephalic vein catheter was placed for drug 
administration.  Fifteen minutes after atropine (0.05 mg 
kg
-1, subcutaneously) injection, each dog was 
intravenously administered tramadol (Maritrol; Je Il 
Pharm. Co. Ltd., Daegu, Korea). Fifteen min later, 
medetomidine (Domitor; Orion Corporation ANIMAL 
HEALTH, Turku, Finland) (40µg kg
-1, intravenously 
[IV]) and ketamine (Ketamine; Yuhan Corp., Seoul, 
Korea) (10mg kg
-1, IV) were given with a 15-min interval.  
 
Behavioral parameters 
Degree of sedation: The degree of sedation was 
assessed by a numerical sedation score (NSS) (Valverde 
et al., 2004). The NSS consists of a scale ranging from 0 
to 3, with 0: no sedation; 1: mild sedation (less sedation 
but still active); 2: moderate sedation (drowsy, recumbent 
but can walk); and 3: intense sedation (very drowsy, 
unable to walk). NSS was evaluated at 30 and 15 min 
after ketamine injection (15 min after tramadol and 
medetomidine injection, respectively), and at 10 and 30 
min after the dogs started showing head-up movement.  
 
Duration of anesthesia: Arousal time after ketamine 
injection to the time the dog showed loss of righting reflex 
(loss of RR), head-up, positioning to a sternal recumbency 
position and walking movements were measured, and the 
mean values were presented (MHT, MST and MWT, 
respectively). The time difference between head-up 
movement and walking was defined as the recovery time.   
 
Duration of surgical anesthesia: The duration of 
surgical anesthesia was determined by pedal withdrawal 
reflex. After ketamine administration, the period in which 
the dog showed negative response to toe-web pinching 
test was defined as surgical anesthesia. Each toe-web 
region in the forelimbs was alternatively pinched with 
mosquito forceps to the first ratchet-lock for 10 sec, and 
was evaluated at 5, 10, 15, 30, 40, 50, 60, 70, 80, 90 and 
120 min from ketamine injection. Additional tests were 
stopped if the dog showed purposeful movement of the 
head and/or limbs.  
 
Blood gas analysis (pH, PaO2, PaCO2) 
Arterial blood sample was collected through the 
external carotid arterial catheter. Blood gas was analyzed 
with a portable blood gas analyzer (I- STAT
® Analyzer 
MN300, Abbott Point of Care Inc., Abbott Park, IL) and 
test cartridges (I - STAT
® G3+ Cartridge, Abbott Point of 
Care Inc., Abbott Park, IL). The blood sample (0.5 mL) 
was collected from the carotid arterial catheter, and the 
catheter was flushed with 0.5 ml of saline diluted heparin, 
following each sampling. The analysis was done within 10 
sec after blood sampling. 
 
Heart rate and mean arterial pressure 
Heart rate and mean arterial blood pressure were 
measured with the polygraph (Model 7P3, Grass 
instrument Co., Quincy, MA). Values were calculated 
from 10-sec arterial pulse wave records in each recording 
time. 
 
Statistical analysis 
All data, except the behavioral parameters, were 
calculated as a percentage to the baseline values, and were 
expressed as mean ± standard deviation (SD). Mean 
arterial blood pressure, heart rate and blood gas values 
were statistically analyzed by two-factor ANOVA 
followed by a Bonferroni correction (SPSS 14.0K, Data 
solution, Seoul, Korea). One-way ANOVA followed by a 
Bonferroni correction were included to identify the 
statistical differences of behavioral changes (time to loss 
of righting reflex, mean head-up time, mean sternal-
recumbency time, mean walking time and total recovery 
time), numerical sedation score and the duration of 
surgical anesthesia. Values of P<0.05 were considered 
significant. 
 
RESULTS 
 
Behavioral parameters 
Degree of sedation: Tramadol (4mg kg
-1) treatment 
resulted in a significant increase of NSS (P=0.001, 
P=0.042 and P=0.007 when compared to control, TRA1 
and TRA2 groups, respectively) at 15 min after tramadol 
administration. In contrast, one-way ANOVA did not 
reveal any significant differences between groups at other 
measurement times (Fig. 1).  
 
Duration of anesthesia: One-way ANOVA revealed 
that no variables of behavioral changes during anesthesia 
were significantly affected by pretreatment with different 
doses of tramadol (F=1.03, P=0.397 in loss of RR; F=1.46, 
P=0.250 in MHT; F=1.46, P=0.251 in MST; F=1.92, 
P=0.153 in MWT; F=1.95, P=0.149 in total recovery 
time) (Fig. 2).  
 
The duration of surgical anesthesia: One-way ANOVA 
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P=0.019), and the Bonferroni test indicated that tramadol 
(4mg kg
-1) pretreatment significantly increased the     
duration   of   surgical   anesthesia   (P=0.023)   when 
compared to the Control group (Fig. 3). 
 
 
Fig. 1: Changes in the degree of sedation in dogs. The dogs 
were given saline, 1, 2 or 4mg kg-1 of tramadol (Control, TRA1, 
TRA2 and TRA4), followed by medetomidine and ketamine. 
The degree of sedation was measured by numerical sedation 
score (NSS) (0, no sedation; 5, severe sedation), and was 
recorded from 15 min after tramadol injection to 30 min after 
the dog showed head-up movement. NSS was not measured 
during anesthesia. TRA4 group exhibited a significant increase in 
NSS (**P=0.001, #P=0.042 and ++P=0.007 compared to Control, 
TRA1 and TRA2 groups, respectively) at 15 min after tramadol 
injection. Data were analyzed by one-way ANOVA and 
Bonferroni test. 
 
 
 
Fig. 2: Duration of anesthesia in dogs anesthetized with 
tramadol, medetomidine and ketamine. The dogs were given 
saline, 1, 2 or 4mg kg-1 of tramadol (Control, TRA1, TRA2 and 
TRA4), followed by medetomidine and ketamine. The 
behavioral changes after ketamine administration were 
measured; average time of latency to loss of righting reflex (RR), 
head-up movement (MHT), sternal recumbential position (MST) 
and walk (MWT) was measured. Additionally, total recovery 
time was determined as the time difference from head-up 
movement to walking-movement. None of the parameters 
showed any significant change by different doses of tramadol. 
Data were analyzed by one-way ANOVA and Bonferroni test. 
 
Blood gas analysis (pH, pO2, pCO2) 
Repeated measures ANOVA revealed that time 
course (F=1.00, P=0.415), interaction (F=0.99, P=0.472) 
 
Fig. 3: Duration of surgical anesthesia was determined by pedal 
withdrawal reflex in dogs anesthetized with tramadol, 
medetomidine and ketamine. The dogs were given saline, 1, 2 
or 4mg kg-1 of tramadol (Control, TRA1, TRA2 and TRA4), 
followed by medetomidine and ketamine. After ketamine 
administration, the period in which the dog showed negative 
response to the toe-web pinching test was defined as the 
surgical anesthesia. The duration of surgical anesthesia in the 
TRA4 group was significantly increased compared with Control 
(*P<0.05, one-way ANOVA and Bonferroni test). 
 
 
 
Fig. 4: C h a n g e s  o f  b l o o d  p H  i n  d o g s  a n e s t h e t i z e d  w i t h  
tramadol, medetomidine and ketamine. The dogs were given 
saline, 1, 2 or 4mg kg-1 of tramadol (Control, TRA1, TRA2 and 
TRA4), followed by medetomidine and ketamine. Data were 
analyzed by two-factor repeated measures ANOVA and 
Bonferroni test, and variables were not significant. 
 
and treatment (F=0.80, P=0.511) were not significant in 
pH variables. Variables of pCO2 and pO2 were 
significantly affected by time course (F=19.43, P<0.001 at 
pCO2, and F=15.35, P<0.001 at pO2), but not interaction 
(F=0.44, P=0.94 at pCO2, and F=0.79, P=0.654 at pO2) or 
treatment (F=0.68, P=0.575 at pCO2, and F=0.31, P=0.815 
at pO2) (Fig. 4-6). 
  
Hemodynamic values 
Heart rate: Repeated measures ANOVA revealed that 
time course was significant (F=35.05, P<0.001), but 
interaction (F=0.50, P=0.993) and treatment (F=0.07, 
P=0.976) were not significant for heart rate (Fig. 7).  
 
Mean arterial blood pressure: Repeated measures 
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(F=11.27, P<0.001), but interaction (F=1.16, P=0.265) 
and treatment (F=0.56, P=0.648) were not significant for 
arterial blood pressure (Fig. 8). 
 
DISCUSSION 
 
The present results show that premedication with 4mg 
kg
-1 of tramadol significantly increased the duration of 
surgical anesthesia of medetomidine and ketamine 
without affecting the hemodynamic parameters or 
delaying the recovery. However, pretreatment with 1 or 
2mg kg
-1  of tramadol failed to extend the expected 
duration of surgical anesthesia. 
 
 
 
Fig. 5: Changes in PaO2 in dogs anesthetized with tramadol, 
medetomidine and ketamine. The dogs were given saline, 1, 2 
or 4mg kg-1 of tramadol (Control, TRA1, TRA2 and TRA4), 
followed by medetomidine and ketamine. Data were analyzed 
by two-factor repeated measures ANOVA and Bonferroni test. 
Time course was significant (P<0.05), but interaction and 
treatment were not significant. 
 
 
 
 
Fig. 6: Changes in PaCO2 in dogs anesthetized with tramadol, 
medetomidine and ketamine. The dogs were given saline, 1, 2 
or 4mg kg-1 of tramadol (Control, TRA1, TRA2 and TRA4), 
followed by medetomidine and ketamine. Data were analyzed 
by two-factor repeated measures ANOVA and Bonferroni test. 
Time course was significant (P<0.05), but interaction and 
treatment were not significant. 
 
Intravenous and epidural administration of tramadol 
(2mg kg
-1) in dogs undergoing soft tissue and orthopedic 
surgery provided effective post-operative analgesia 
(Vettorato et al., 2010), and 2mg kg
-1 of tramadol had an 
analgesic potency comparable to that of 0.2mg kg
-1 of 
morphine (Mastrocinque and Fantoni, 2003). In addition, 
constant rate infusion of tramadol also had MAC-reducing 
effects in dogs (Seddighi et al., 2009). In contrast, some 
results have indicated that pretreatment with a single 
bolus of tramadol for anesthesia was insufficient to obtain 
a significant level of enhanced surgical general anesthesia 
(Kongara et al., 2010).  
 
 
 
 
Fig. 7: Changes in heart rates in dogs anesthetized with 
tramadol, medetomidine and ketamine. The dogs were given 
saline, 1, 2 or 4mg kg-1 of tramadol (Control, TRA1, TRA2 and 
TRA4), followed by medetomidine and ketamine. Data were 
analyzed by two-factor repeated measures ANOVA and 
Bonferroni test. Time course was significant (P<0.05), but 
interaction and treatment were not significant. 
 
 
 
 
Fig. 8: Changes in mean arterial pressure (MAP) in dogs 
anesthetized with tramadol, medetomidine and ketamine. The 
dogs were given saline, 1, 2 or 4mg kg-1 of tramadol (Control, 
TRA1, TRA2 and TRA4), followed by medetomidine and 
ketamine. Data were analyzed by two-factor repeated measures 
ANOVA and Bonferroni test. Time course was significant 
(P<0.05), but interaction and treatment were not significant. 
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Recent pharmacokinetics results of tramadol in 
beagles suggested that lower M1 plasma concentration 
levels were detected in dogs, and the M1 metabolite is an 
important analgesic contributor of tramadol (McMillan et 
al., 2008; Giorgi et al., 2009a). Prior to our experiment, 
we anticipated that the 2mg kg
-1 dose of tramadol could 
significantly extend the duration of surgical anesthesia 
and that 4mg kg
-1 of tramadol would extend not only the 
period of surgical anesthesia but also the recovery 
duration. We also surmised that this prolonged recovery 
would be the main reason to select 2mg kg
-1 of tramadol 
for the pretreatment dose. However, 1 and 2mg kg
-1 doses 
of tramadol pretreatment were ineffective in enhancing 
the duration of surgical anesthesia in the present study. 
Effective enhancement only at the higher dose of tramadol 
could be related to the low level of M1 metabolites in 
dogs as mentioned earlier. Furthermore, a rapid 
elimination rate of tramadol in dogs cannot be ruled out 
(McMillan et al., 2008). The higher dose of tramadol 
resulted in higher and more sustained tramadol plasma 
concentration (McMillan et al., 2008), and tramadol itself 
seemed to have an analgesic effect in dogs (Giorgi et al., 
2009a). In the present study, tramadol was injected 30 min 
before ketamine administration, and a relatively long time 
passed in order to differentiate the duration of surgical 
anesthesia and compare it to the control group. That is, in 
the early period of anesthesia, the effect of tramadol could 
be masked by medetomidine and ketamine, but as the 
anesthetic time passed, the efficacy of tramadol as well as 
medetomidine and ketamine could be attenuated. In this 
situation, the higher tramadol plasma concentration would 
contribute to the enhancement of anesthetic depth. 
In the present study, only treatment with 4mg kg
-1 of 
tramadol induced a sedative effect at 15 min after 
tramadol administration. Previous results about the 
sedative effect of tramadol were controversial; one 
described a dose-dependent sedative effect of tramadol 
(Mastrocinque and Fantoni, 2003; Turker et al., 2005; 
McMillan et al., 2008), but another study reported no 
marked sedation (Seddighi et al., 2009). However, 
significant sedation was induced with 4mg kg
-1 of 
tramadol in the present study, but none of the doses of 
tramadol tested affected the anesthetic induction (no 
significant difference in loss of RR) or behavioral changes 
during recovery, and the sedative effect of tramadol did 
not persist for long.     
Tramadol premedication did not cause a clinically 
important sedation in dogs during the recovery period 
(Seddighi et al., 2009). In the present study, variables of 
behavioral changes were not significantly affected by 
different doses of tramadol, although a dose-dependent 
delay was observed. That is, tramadol premedication did 
not affect the recovery time, and the higher dose of 
tramadol in the present study prolonged the surgical 
anesthesia without hangover.  
Previous results demonstrated that tramadol 
premedication has minimal effects on hemodynamics and 
respiratory function during anesthesia (Mastrocinque and 
Fantoni, 2003; McMillan et al., 2008; Seddighi et al., 
2009). Dogs given tramadol premedication showed no 
significant changes in blood pressure, heart rate, arterial 
blood gases and pH during isoflurane anesthesia 
(Mastrocinque and Fantoni, 2003). The results of our 
study were consistent with the previously published 
results. 
In conclusion, tramadol premedication at a dose of 
4mg kg
-1 can significantly increase the duration of 
surgical anesthesia with medetomidine and ketamine in 
dogs, without imparting significant changes to the 
cardiovascular system or recovery from anesthesia. 
Therefore, this study suggests that 4mg kg
-1 of tramadol 
may be a useful preanesthetic agent for sustaining the 
level of surgical anesthesia longer in medetomidine and 
ketamine anesthesia in dogs. 
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